Blood marker study halted: could uPAR predict drug success?
Knowledge-focused
Terminated
This study aimed to see if a substance in the blood called uPAR could help doctors predict whether men with advanced prostate cancer would respond to the drug abiraterone. Only 3 men were enrolled before the study was stopped early. The goal was to find a simple blood test to gui…
Sponsor: Kristoffer Rohrberg • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC